We reported that the PMI, combined with the concentration of citrullinated histone H3 (CH3) and osteocalcin (BGLAP), may help identify patients with congenital hemophilia requiring additional diagnostics for reduced bone mass. The gene discussed is BGLAP; the disease is hemophilia.